Adding Two New Drug Classes Improves Outcome in Salvage Therapy
In patients experiencing treatment failure on an NRTI regimen, adding both a PI and an NNRTI to salvage therapy resulted in significant virologic improvements compared with adding a drug from either class alone.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)